Limited Use Note(s)
SALMETEROL XINAFOATE & FLUTICASONE PROPIONATE
25/250mcg/Metered Dose Inh-120 Dose Pk
New Search
Reason For Use Code
Clinical Criteria
330
For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.
LU Authorization Period: Indefinite
Back
New Search
